Skip to main content
BGM
NASDAQ Life Sciences

BGM Group Closes $12M Private Placement at Deep Discount

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.333
Mkt Cap
$58.849M
52W Low
$0.256
52W High
$17.17
52W Position info
30% above low
Off High info
98% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

BGM sits 30% above its 52-week low of $0.256.

Summary

BGM Group Ltd. has finalized its $12 million private placement, issuing 200 million shares and warrants at a deep discount, as previously announced.


Key Events · Financing and Capital Events · BGM

  • Private Placement Closed

    The company completed its private placement on June 8, 2026, raising gross proceeds of $12,000,000.

  • Significant Share Issuance

    200,000,000 Class A ordinary shares were issued at a subscription price of $0.06 per share, along with warrants to purchase an aggregate of 200,000,000 Class A Ordinary Shares.

  • Deep Discount Offering

    The offering price of $0.06 per share represents a substantial discount compared to the current market price of $0.3329, resulting in significant dilution for existing shareholders.


Analysis · BGM · Life Sciences

This filing confirms the completion of a previously announced private placement, which involved issuing 200 million shares and warrants for $12 million. While providing crucial capital for the company, the offering was priced at a significant discount to the market, leading to substantial dilution for existing shareholders.

How filings like this one have moved

In the 30 days to Sep 15, 2026, 29.9% of the 1678 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.25%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BGM was trading at $0.33 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $58.8M. The 52-week trading range was $0.26 to $17.17. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BGM - Latest Insights

BGM
Aug 28, 2026, 9:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.2804
Real-time Price: $0.2472 info
Change: -$0.0332 (-12%) info
Market Cap: $103.978M info
BGM
Aug 11, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.291
Real-time Price: $0.2472 info
Change: -$0.0438 (-15%) info
Market Cap: $103.978M info
BGM
Jul 30, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.2718
Real-time Price: $0.2472 info
Change: -$0.0246 (-9%) info
Market Cap: $103.978M info
BGM
Jul 21, 2026, 9:02 AM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $0.2805
Real-time Price: $0.2472 info
Change: -$0.0333 (-12%) info
Market Cap: $103.978M info
BGM
Jun 17, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.388
Real-time Price: $0.2472 info
Change: -$0.1408 (-36%) info
Market Cap: $103.978M info